Your browser doesn't support javascript.
loading
Advanced coronary artery disease: Appropriate end points for trials of novel therapies.
Kandzari, D E; Lam, L C; Eisenstein, E L; Clapp-Channing, N; Fine, J T; Califf, R M; Mark, D B; Jollis, J G.
Affiliation
  • Kandzari DE; Division of Cardiology and Duke Clinical Research Institute, Duke University Medical Center, Durham, NC, USA. kandz002@onyx.dcri.duke.edu
Am Heart J ; 142(5): 843-51, 2001 Nov.
Article in En | MEDLINE | ID: mdl-11685173
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Clinical Trials as Topic / Coronary Disease Type of study: Prognostic_studies Aspects: Patient_preference Limits: Humans Language: En Journal: Am Heart J Year: 2001 Document type: Article Affiliation country: Country of publication:
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Clinical Trials as Topic / Coronary Disease Type of study: Prognostic_studies Aspects: Patient_preference Limits: Humans Language: En Journal: Am Heart J Year: 2001 Document type: Article Affiliation country: Country of publication: